-
1
Porphyromonas gingivalis-induced periodontitis promotes neuroinflammation and neuronal loss associated with dysfunction of the brain barrier
Published 2025-06-01Subjects: Get full text
Article -
2
A new pathway for neuroprotection against tau hyperphosphorylation via δ-opioid receptor initiated inhibition of CDK5 and AMPK signaling
Published 2025-06-01Subjects: Get full text
Article -
3
Avenanthramide-C as Alzheimer’s Disease-Modifying Therapy: Early and Sustained Intervention Prevents Disease Progression in Mouse Models
Published 2025-06-01Subjects: Get full text
Article -
4
Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
Published 2016-11-01Subjects: Get full text
Article -
5
Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
Published 2025-02-01Subjects: Get full text
Article -
6
Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
Published 2024-12-01Subjects: Get full text
Article -
7
-
8
-
9
The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment
Published 2023-05-01Subjects: Get full text
Article -
10
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
Published 2025-10-01Subjects: Get full text
Article -
11
Identification of a novel pyrrolo[2,3-b]pyridine compound as a potent glycogen synthase kinase 3β inhibitor for treating Alzheimer’s disease
Published 2025-12-01Subjects: Get full text
Article -
12
Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
Published 2026-02-01Subjects: Get full text
Article -
13
PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron
Published 2025-07-01Subjects: Get full text
Article